Tie-1 inhibitors belong to a distinct chemical class of compounds that target a specific protein known as Tyrosine kinase with immunoglobulin-like and EGF-like domains 1 (Tie-1). Tie-1 is a receptor tyrosine kinase, which means it plays a crucial role in transmitting signals within cells and regulating various cellular processes. These inhibitors are designed to modulate the activity of Tie-1, making them valuable tools for researchers studying Tie-1's functions and implications in different biological contexts.
The structure of Tie-1 inhibitors typically comprises small molecules or peptides that can interact with the kinase domain of Tie-1, inhibiting its enzymatic activity. By doing so, these inhibitors can alter the downstream signaling pathways that Tie-1 is involved in, influencing processes like cell growth, differentiation, and migration. This makes Tie-1 inhibitors valuable in elucidating the physiological and pathological roles of Tie-1 in various cellular processes, as well as exploring avenues that may arise from a better understanding of Tie-1's functions. Researchers utilize Tie-1 inhibitors in laboratory settings to investigate Tie-1's involvement in angiogenesis, vascular development, and other processes, shedding light on its intricate role in maintaining tissue homeostasis and identifying novel targets for further research and development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $150.00 $920.00 | 5 | |
Sunitinib is another multikinase inhibitor with the potential to inhibit Tie-1, potentially affecting the angiopoietin-Tie signaling pathway, which plays a crucial role in angiogenesis and the maintenance of vascular integrity. | ||||||
Pazopanib Hydrochloride | 635702-64-6 | sc-364564 sc-364564A | 10 mg 25 mg | $107.00 $230.00 | 1 | |
Pazopanib Hydrochloride is a tyrosine kinase inhibitor that targets multiple receptors and might inhibit Tie-1, possibly affecting endothelial cell function and angiogenesis. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Imatinib is a tyrosine kinase inhibitor that primarily targets BCR-ABL, but it has been shown to inhibit other kinases as well, potentially including Tie-1. This could affect the signaling pathways involved in vascular development and stability. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $85.00 $132.00 $287.00 $495.00 $3752.00 | 42 | |
Erlotinib is an epidermal growth factor receptor (EGFR) inhibitor that may also have the potential to inhibit Tie-1, possibly interfering with the angiopoietin-Tie signaling pathway and affecting vascular development and integrity. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $62.00 $112.00 $214.00 $342.00 | 74 | |
Gefitinib is another EGFR inhibitor that could potentially inhibit Tie-1, potentially affecting angiogenesis and vascular stability. | ||||||
XL-184 free base | 849217-68-1 | sc-364657 sc-364657A | 5 mg 10 mg | $92.00 $204.00 | 1 | |
XL-184 is a multikinase inhibitor with the potential to inhibit Tie-1, possibly affecting the signaling pathways involved in vascular development and the maintenance of blood vessel integrity. | ||||||
BIBF1120 | 656247-17-5 | sc-364433 sc-364433A | 5 mg 10 mg | $180.00 $315.00 | 2 | |
BIBF1120 is a kinase inhibitor that targets multiple tyrosine kinases, and it might inhibit Tie-1, potentially disrupting angiogenesis and vascular stability. | ||||||